William Wood
Stock Analyst at B. Riley Securities
(2.05)
# 3,233
Out of 5,040 analysts
62
Total ratings
37%
Success rate
0.7%
Average return
Main Sectors:
Stocks Rated by William Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Reiterated: Buy | $85 | $36.75 | +131.29% | 3 | Sep 25, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $11 → $8 | $2.91 | +174.91% | 11 | Sep 11, 2026 | |
| MBOT Microbot Medical | Initiated Coverage: Buy | $4 | $1.31 | +205.34% | 1 | Sep 11, 2026 | |
| IMUX Immunic | Reiterated: Buy | $27 | $9.32 | +189.70% | 11 | Sep 2, 2026 | |
| TGTX TG Therapeutics | Reiterated: Buy | $86 | $57.52 | +49.51% | 3 | Sep 2, 2026 | |
| IBIO iBio, Inc. | Initiated Coverage: Buy | $6 | $1.20 | +400.00% | 1 | Aug 31, 2026 | |
| ACOG Alpha Cognition | Initiated Coverage: Buy | $21 | $8.57 | +145.04% | 1 | Aug 20, 2026 | |
| AGMB AgomAb Therapeutics NV | Initiated Coverage: Buy | $34 | $10.58 | +221.36% | 1 | Jul 23, 2026 | |
| TRVI Trevi Therapeutics | Reiterated: Buy | $31 | $14.68 | +111.24% | 1 | Jul 17, 2026 | |
| EQ Equillium | Reiterated: Buy | $6 | $1.72 | +248.84% | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.57 | +345.86% | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $5.47 | +27.97% | 3 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.04 | +327.63% | 1 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $560 → $670 | $513.21 | +30.55% | 3 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.38 | +262.32% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.9508 | +215.52% | 1 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $2.51 | n/a | 7 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $14.61 | n/a | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $3.27 | n/a | 4 | May 2, 2024 |
Viking Therapeutics
Sep 25, 2026
Reiterated: Buy
Price Target: $85
Current: $36.75
Upside: +131.29%
LifeMD
Sep 11, 2026
Reiterated: Buy
Price Target: $11 → $8
Current: $2.91
Upside: +174.91%
Microbot Medical
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $1.31
Upside: +205.34%
Immunic
Sep 2, 2026
Reiterated: Buy
Price Target: $27
Current: $9.32
Upside: +189.70%
TG Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $86
Current: $57.52
Upside: +49.51%
iBio, Inc.
Aug 31, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $1.20
Upside: +400.00%
Alpha Cognition
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $8.57
Upside: +145.04%
AgomAb Therapeutics NV
Jul 23, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $10.58
Upside: +221.36%
Trevi Therapeutics
Jul 17, 2026
Reiterated: Buy
Price Target: $31
Current: $14.68
Upside: +111.24%
Equillium
Jun 2, 2026
Reiterated: Buy
Price Target: $6
Current: $1.72
Upside: +248.84%
Jun 2, 2026
Reiterated: Buy
Price Target: $7
Current: $1.57
Upside: +345.86%
May 15, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $5.47
Upside: +27.97%
Mar 6, 2026
Reiterated: Buy
Price Target: $13
Current: $3.04
Upside: +327.63%
Dec 11, 2025
Reiterated: Buy
Price Target: $560 → $670
Current: $513.21
Upside: +30.55%
Dec 8, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.38
Upside: +262.32%
Nov 21, 2025
Reiterated: Buy
Price Target: $3
Current: $0.9508
Upside: +215.52%
Feb 11, 2025
Reiterated: Buy
Price Target: $50
Current: $2.51
Upside: n/a
May 8, 2024
Reiterated: Buy
Price Target: $10
Current: $14.61
Upside: n/a
May 2, 2024
Reiterated: Buy
Price Target: $4
Current: $3.27
Upside: n/a